Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websiteaviir.com
Blogaviir.com/blog
Twitter@AviirLabs
CategoryBioTech
Phone (949) 398-6300
Emailclientservices@av...
Employees
Founded2005
DescriptionCardiovascular Diagnostic Development

Offices

Irvine, USA
9805 Research Drive
Irvine, CA, 92618
USA

People

CEO, Board of Directors
Chief Financial Officer
Board of Directors
Board of Directors
Board of Directors
Board of Directors
Board of Directors
Director, International Business Development
Show All People

Funding

Tags

Aviir

Aviir is a venture-funded biotechnology company developing cutting-edge, diagnostic tests enabling accurate diagnosis and prognosis of cardiovascular disease. The company’s proprietary technology is based on ten years of research at Stanford University, and combines the scientific founder’s deep understanding of biomarker assay development and advanced biostatistics. Aviir has pursued an aggressive commercialization strategy, and initial products, including the MIRISK VP™ test, are currently on the market. The Aviir leadership team includes the founding scientists and highly experienced management.

Recent Milestones

  • Dollar
    Aviir received $10M in Series B funding. (6/21/13)
    Posted 6/21/13 at 4:45am via finsmes.com
  • Dollar
    Aviir received $10M in Series B funding. (2/12/13)
    Posted 8/21/13 at 6:08am via socaltech.com
  • Dollar
    Aviir received $8M in Debt funding. (9/19/12)
    Posted 9/19/12 at 7:52pm via dowjones.com
  • Dollar
    Aviir received $10M in Series B funding. (12/20/11)
    Posted 12/20/11 at 5:25am via pehub.com
  • Dollar
    Aviir received $3M in Venture Round funding. (6/21/11)
    Posted 8/21/13 at 6:04am via sec.gov
  • Dollar
    Aviir received $4.2M in Venture Round funding. (1/15/10)
    Posted 1/20/10 at 10:04pm via venturebeat.com
  • Dollar
    Aviir received $1M in Venture Round funding. (10/19/09)
    Posted 11/8/09 at 8:12pm via venturebeat.com
  • Dollar
    Aviir received $1M in Venture Round funding. (8/5/09)
    Posted 8/21/13 at 5:57am via sec.gov
  • Dollar
    Aviir received $7.8M in Venture Round funding. (12/2/08)
    Posted 8/21/13 at 5:56am via venturebeat.com
  • Dollar
    Aviir received $1.5M in Venture Round funding. (3/19/08)
    Posted 8/21/13 at 5:54am via venturebeat.com
  • Dollar
    Aviir received $11.4M in Venture Round funding. (9/20/07)
    Posted 7/15/09 at 8:44am via venturebeat.com
  • Dollar
    Aviir received $1.45M in Convertible Note funding. (8/10/07)
    Posted 8/21/13 at 5:45am via sec.gov
  • Dollar
    Aviir received $130k in Venture Round funding. (3/1/07)
    Posted 8/20/13 at 2:09pm via sec.gov
  • Dollar
    Aviir received $1.5M in Venture Round funding. (10/24/06)
    Posted 8/20/13 at 2:02pm via sec.gov
  • Check
    Aviir added Paul Klingenstein as Boards of Directors.
    Posted 12/29/13 at 12:54am

Videos

Screenshots

Sources

  1. SEC Filing (sec.gov) [edit]
  2. SEC Filing (sec.gov) [edit]
  3. SEC Filing (sec.gov) [edit]
  4. Heart-diagnostic maker Aviir raises $11.3M (venturebeat.com) [edit]
  5. Life-science briefing: Wednesday, March 26, 2008 (follow-on to $11.3m round) (venturebeat.com) [edit]
  6. Aviir pumps in $7.8M for heart diagnostics (venturebeat.com) [edit]
  7. SEC Filing (sec.gov) [edit]
  8. Aviir pumps up with $1M for heart diagnostics (venturebeat.com) [edit]
  9. Aviir diagnoses heart conditions with new $4.2M (venturebeat.com) [edit]
  10. SEC (sec.gov) [edit]
  11. Aviir Seals Agreement for Up to $30M in Funding (pehub.com) [edit]
  12. Aviir Borrows $8M for Heart-Disease Tests (pevc.dowjones.com) [edit]
  13. Aviir Snags $10M In Second Tranche Financing (socaltech.com) [edit]
  14. Aviir Raises Additional $10M (finsmes.com) [edit]
Edit This Page
Last Edited 4/15/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy